Irvine Mason
Neurology · Parkland, FLNPI 1952302655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Novartis at 35.6% of the total. Reporting peaked in 2019 at $714 and has fallen 84.7% since, to $109 in 2025. That places this record below the midpoint for neurology clinicians in FL, where the typical reported total is $1,698.
Across 58 payments — averaging $19.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$396
- Biotronik NRO, Inc.$90
- Amgen$78
- Avanir Pharmaceuticals, Inc.$65
- Acadia Pharmaceuticals Inc$61
- AstraZeneca$54
- plus $370 from 15 others
What the payments were for
- Food & beverage$1,115100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 23 | $396 |
| Biotronik NRO, Inc. | 1 | $90 |
| Amgen | 5 | $78 |
| Avanir Pharmaceuticals, Inc. | 3 | $65 |
| Acadia Pharmaceuticals Inc | 4 | $61 |
| AstraZeneca | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| EMD Serono, Inc. | 2 | $33 |
| AbbVie | 2 | $32 |
| Eisai Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $26 |
| Kvk-tech, Inc. | 1 | $25 |
| CSL Behring | 1 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $21 |
| Forte Bio-pharma LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Vertex | 1 | $19 |
| Merz North America, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,115 in reported general payments places this provider in the 40th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 23 | $16,741 |
| Xtampza ErOxycodone Myristate | 14 | $14,438 |
| Oxycodone Hcl | 241 | $6,185 |
| Morphine Sulfate ErMorphine Sulfate | 28 | $1,979 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 48 | $1,551 |
| Ibuprofen | 137 | $1,025 |
| Morphine Sulfate | 16 | $499 |
| Hydromorphone Hcl | 11 | $430 |
| Gabapentin | 53 | $389 |
| Pregabalin | 19 | $245 |
| Methadone Hcl | 26 | $177 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 58 | $96 |
| Cyclobenzaprine Hcl | 25 | $47 |
Paid to pharmacies, not to this prescriber.
Other neurology in Parkland
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.